Clinical trial NCT05916664: Efficacy Study of Kinto Care Coaching for Dementia Family Caregivers
Official title: Phase II Efficacy Study of a Technology-enabled Care Coaching Service for Families Caring for AD/ADRD
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Dementia
Alzheimer Disease
Lewy Body Disease
Vascular Dementia
Frontotemporal Dementia
Mixed Dementia
Keywords: Caregiving
Financial Education
Technology
Behavioral Intervention
Caregiver Support Intervention
Financial Literacy
Financial Preparedness
Caregiver Well Being
Caregiver Stress
Caregiver Burden
Lead sponsor: Kinto
Sponsor class: INDUSTRY
Collaborators: name: Alzheimer's Association
First posted: 2023-06-23
Enrollment: 495
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: The goal of this clinical trial is to evaluate Kinto's Care Coaching intervention for dementia caregivers.

The main questions it aims to answer are:

Does the intervention help caregivers to address their general caregiving goals Does the intervention help caregivers to address their financial caregiving goals

Participants will have access to:

One-on-one care coaching sessions (via zoom) Up to 6 weekly support groups with other caregivers A variety of digital resources through Kinto's mobile app

Researchers will compare intervention and control groups to see if the program supports caregivers' general and financial caregiving needs.

The efficacy of the intervention also will be examined on key outcomes.

Detailed description: The study will include 300 family caregivers drawn from throughout the US, who will engage remotely with the coaches (and one another) using zoom and Kinto's mobile caregiver app.

Caregivers will be randomly assigned to one of two groups to evaluate the impact of the program by making a comparison of those caregivers who received the program (Group

1) and those caregivers who will not receive the program (Group 2). Caregivers assigned to Group 2, the control condition, will be eligible to receive a modified version of the program after completion of the study and data collection protocols.

The intervention is a care coaching program that assists caregivers with their general caregiving goals and financial caregiving goals. Caregivers will attend a one-on-one care coaching session conducted via Zoom for 60-75 minutes with a care coach and will engage with their care coach through chat-based interactions after completing the session. If requested, up to two additional care coaching sessions will be scheduled.

Caregivers also will have the opportunity to attend up to 6 weekly support groups with other caregivers facilitated by a care coach and receive a variety of digital resources through the mobile app.

As guided by the NIH Stage Model for Behavioral Intervention Development, the primary goal of the Phase 2 study is to examine the efficacy of the program on select outcomes for caregivers (i.e., Stage III Real-World Efficacy). As such, the selected data collection periods of T1 (prior to the intervention), T2 (immediately following the initial six week intervention period) and T3 (45 days following this date) will evaluate the immediate and short-term efficacy of the program.

Recruiting of caregivers is scheduled to begin in May 2023. The study plan targets recruitment of three cohorts, each with one hundred participants. The first intervention group will begin the program in August 2023. Subsequent cohorts will begin the study at 8-9 week intervals. The plan includes a contingency to run two additional cohorts (to mitigate any recruitment or retention risk). In the event that all five cohorts are used to achieve participation goals, the final cohort is scheduled to complete the intervention and survey requirements no later than August of 2024.

Eligibility criteria: Inclusion Criteria:

Participants must be:

* 18 years or older
* Caring for a family member or close friend with dementia or memory loss
* Providing 5 or more hours of care or support each week
* Not getting paid for the care/support
* Fluent in English, or both Spanish and English
* Living in the United States

They must:

● Have access to a smart phone, reliable internet service and an email address

Exclusion Criteria:

Participants can not:

* Currently be participating in another non-pharmacological intervention
* Have participated in a previous Kinto study

Primary outcomes:
measure: Caregiver Mastery
timeFrame: Changes in caregiver mastery between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Emotional Health Strain
timeFrame: Changes in emotional health strain between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Personal Gain
timeFrame: Changes in personal gain between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Financial Self-Efficacy
timeFrame: Changes in financial self-efficacy between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: ULS-8 Loneliness Scale
timeFrame: Changes in loneliness between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Perceived Financial Knowledge
timeFrame: Changes in perceived financial knowledge between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Caregiver Burden
timeFrame: Changes in caregiver burden between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
Secondary outcomes:
measure: Dyadic Relationship Strain
timeFrame: Changes in relationship strain between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Role Captivity
timeFrame: Changes in role captivity between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Caregiver Unmet Needs
timeFrame: Changes in unmet needs between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Caregiver Unmet Needs Distress
timeFrame: Changes in unmet needs distress between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Anxiety
timeFrame: Changes in anxiety symptoms between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Depression
timeFrame: Changes in depressive symptoms between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Instrumental and Personal Activities of Daily Living - Difficulty
timeFrame: Changes in instrumental activities of daily living difficulty between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Instrumental and Personal Activities of Daily Living - Distress
timeFrame: Changes in instrumental activities of daily living distress between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Cognition - Difficulty
timeFrame: Changes in cognitive difficulty between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Cognition - Distress
timeFrame: Changes in cognitive distress between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Behaviors - Frequency
timeFrame: Changes in behavioral frequency between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
measure: Behaviors - Distress
timeFrame: Changes in behavioral distress between the control and intervention conditions will be evaluated across time from T1 (baseline) to T2 (post-intervention completion/6-weeks from baseline) and T3 (45 days from T2).
Other outcomes:
Locations:
city: Chicago
country: United States
facility: Alzheimer's Association Head Office
state: Illinois
Study officials:
References: